|
|
 |
|
Viewing report
|
|
|
|
Lung Cancer Therapeutics - Global Strategic Business Report
Global Industry Analysts, Inc., July 2009, Pages: 842
This report analyzes the worldwide markets (Annual Revenues) for Lung Cancer Therapeutics in Millions of US$. The US market for Non-Small Cell Lung Cancer treatment is further analyzed by: Chemotherapy Drugs, and Targeted Drugs. The report provides separate comprehensive analytics for the US, Europe and Rest of World. Annual forecasts are provided for each region for the period 2005 through 2015.
The report profiles 191 companies including many key and niche players worldwide such as
- AstraZeneca PLC.
- Bristol-Myers Squibb Co.
- Eli Lilly & Co.
- F. Hoffmann-La Roche Ltd.
- Genentech, Inc.
- GlaxoSmithKline Plc.
- Novartis Pharmaceuticals Corporation
- OSI Pharmaceuticals, Inc.
- Sanofi-Aventis
- AbGenomics International Inc.
- ImClone Systems, Inc.
- Pfizer, Inc.
- Merck Serono International S.A.
- Merck & Co. Ltd.
- Telik, Inc.
- Woomera Therapeutics, Inc.
Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on Enquire before buying
Customers who bought this item also bought
Lung Cancer Therapeutics Market Outlook and Pipeline Analysis
Angiogenesis Inhibitors and Stimulators - Global Strategic Business Report
Prostate Cancer Therapeutics - Global Strategic Business Report
Bladder Cancer Therapeutics - Global Strategic Business Report
Drug Delivery in Cancer - Technologies, Markets and Companies
Small Molecule Kinase Inhibitors - Global Strategic Business Report
Cancer Drug Discoveries: What the Future Holds: Non-Small Cell Lung Cancer Chapter
The Global Cancer Vaccine Market, 2nd Edition: Pipeline Analysis and Future Market Impact
Lung Cancer Therapeutic Antibodies: Pipeline, Strategies and Clinical
Melanoma Therapeutics - Global Strategic Business Report
|
|
|
|
